By clicking Accept All, you consent to the use of ALL the cookies
Regular check-ins every 48 weeks allow providers to monitor side effects, blood sugar, blood pressure, and medication tolerability, making adjustments before minor concerns become major problems
The most common adverse reactions reported in clinical trials are gastrointestinal, including nausea, diarrhea, and constipation
Certain medications may require closer monitoring when taken with semaglutide, especially those that affect blood sugar, digestion, or appetite
This comprehensive support saves you time and frustration
High-quality formulations tend to yield better and safer outcomes